Clinical trials
Phase 1 Nervous System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 3 |
| Terminated | 2 |
| Unknown status | 1 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Alzheimer's Disease Expert Lab (ADEL), Inc. | 1 |
| AstraZeneca | 1 |
| Brigham and Women's Hospital | 1 |
| Cerevel Therapeutics, LLC | 1 |
| DNAtrix, Inc. | 1 |
| Edgewise Therapeutics, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Forest Hills Lab | 1 |
| Healeon Medical Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 21 |
| Central Nervous System Diseases | 9 |
| Brain Diseases | 8 |
| Neurodegenerative Diseases | 6 |
| Mental Disorders | 4 |
| Movement Disorders | 4 |
| Muscular Diseases | 4 |
| Musculoskeletal Diseases | 4 |
| Neuromuscular Diseases | 4 |
| Dementia | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.